6 Result(s)

Article

Correction to: Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth

The original article can be found online.

Heath McAnally, Udo Bonnet, Alan D. Kaye in Pain and Therapy (2021)

Article

Response to Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”

Heath B. McAnally, Udo Bonnet in Pain and Therapy (2021)

Article

Comment on “Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update”

Udo Bonnet, Heath McAnally, Norbert Scherbaum in Drugs (2021)

Article

Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth

Recent years have seen a dramatic escalation of off-label prescribing for gabapentin and pregabalin (gabapentinoids) owing in part to generic versions of each being released over the past two decades, but also...

Heath McAnally, Udo Bonnet, Alan D. Kaye in Pain and Therapy (2020)

Article

Erratum to: Recurrent purpura due to alcohol-related Schamberg’s disease and its association with serum immunoglobulins: a longitudinal observation of a heavy drinker

Udo Bonnet, Claudia Selle, Katrin Isbruch in Journal of Medical Case Reports (2016)

Article

Recurrent purpura due to alcohol-related Schamberg’s disease and its association with serum immunoglobulins: a longitudinal observation of a heavy drinker

It is unusual for purpura to emerge as a result of drinking alcohol. Such a peculiarity was observed in a 55-year-old man with a 30-year history of heavy alcohol use.

Udo Bonnet, Claudia Selle, Katrin Isbruch… in Journal of Medical Case Reports (2016)